BR0014548A - Tratamento de endometriose ou de infertilidade, ou melhoramento de fertilidade - Google Patents
Tratamento de endometriose ou de infertilidade, ou melhoramento de fertilidadeInfo
- Publication number
- BR0014548A BR0014548A BR0014548-3A BR0014548A BR0014548A BR 0014548 A BR0014548 A BR 0014548A BR 0014548 A BR0014548 A BR 0014548A BR 0014548 A BR0014548 A BR 0014548A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- endometriosis
- infertility
- fertility
- improvement
- Prior art date
Links
- 201000009273 Endometriosis Diseases 0.000 title abstract 3
- 230000035558 fertility Effects 0.000 title abstract 3
- 230000036512 infertility Effects 0.000 title abstract 3
- 208000000509 infertility Diseases 0.000 title abstract 3
- 231100000535 infertility Toxicity 0.000 title abstract 3
- 239000000808 adrenergic beta-agonist Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000009897 systematic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
"TRATAMENTO DE ENDOMETRIOSE OU DE INFERTILIDADE, OU MELHORAMENTO DE FERTILIDADE". A presente invenção refere-se a composições e a métodos para o uso de agonista beta-adrenérgico para o tratamento de endometriose, para o tratamento de infertilidade e para melhoramento de fertilidade. A presente invenção ulteriormente refere-se a formulação de tal composição ou método em um tal modo que proveja níveis terapeuticamente suficientes do agonista beta-adrenérgico localmente enquanto evitando concentrações sistemáticas adversas no hospedeiro, desse modo minimizando ou evitando os efeitos colaterais.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15775499P | 1999-10-05 | 1999-10-05 | |
| US66838400A | 2000-09-25 | 2000-09-25 | |
| PCT/EP2000/009708 WO2001024788A2 (en) | 1999-10-05 | 2000-10-04 | Treating endometriosis or infertility, or improving fertility |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0014548A true BR0014548A (pt) | 2002-06-04 |
Family
ID=26854456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0014548-3A BR0014548A (pt) | 1999-10-05 | 2000-10-04 | Tratamento de endometriose ou de infertilidade, ou melhoramento de fertilidade |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP1220667B1 (pt) |
| JP (2) | JP2003510354A (pt) |
| KR (1) | KR100738724B1 (pt) |
| CN (1) | CN1218694C (pt) |
| AR (1) | AR028487A1 (pt) |
| AT (1) | ATE271860T1 (pt) |
| AU (1) | AU780736B2 (pt) |
| BR (1) | BR0014548A (pt) |
| CA (1) | CA2385974C (pt) |
| CO (1) | CO5251423A1 (pt) |
| DE (1) | DE60012554T2 (pt) |
| DK (1) | DK1220667T3 (pt) |
| ES (1) | ES2223581T3 (pt) |
| GE (1) | GEP20043313B (pt) |
| HK (1) | HK1044120B (pt) |
| HU (1) | HU225990B1 (pt) |
| IL (2) | IL148784A0 (pt) |
| MA (1) | MA25501A1 (pt) |
| MX (1) | MXPA02003453A (pt) |
| MY (1) | MY129518A (pt) |
| NO (1) | NO329663B1 (pt) |
| NZ (1) | NZ518429A (pt) |
| PE (1) | PE20010742A1 (pt) |
| PT (1) | PT1220667E (pt) |
| TR (1) | TR200200899T2 (pt) |
| TW (1) | TWI280877B (pt) |
| UA (1) | UA74168C2 (pt) |
| WO (1) | WO2001024788A2 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8425892B2 (en) | 2001-10-29 | 2013-04-23 | Columbia Laboratories, Inc. | Extended, controlled-release pharmaceutical compositions using charged polymers |
| CN101327326A (zh) * | 2001-10-29 | 2008-12-24 | 哥伦比亚实验室(百慕大群岛)有限公司 | 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂 |
| ES2237298B1 (es) | 2003-07-16 | 2006-11-01 | Italfarmaco, S.A. | Formulaciones mucoadhesivas semisolidas. |
| EP1872775A1 (en) | 2006-06-29 | 2008-01-02 | Polichem S.A. | Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
| ES2344673B1 (es) | 2008-08-07 | 2011-05-03 | Italfarmaco, S.A. | Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral. |
| ES2344675B1 (es) | 2008-12-19 | 2011-04-28 | Italfarmaco, S.A. | Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular. |
| MX2012010327A (es) * | 2010-03-22 | 2012-11-16 | Repros Therapeutics Inc | Composiciones y metodos para la administracion no toxica de antiprogestinas. |
| KR101010031B1 (ko) * | 2010-12-08 | 2011-01-21 | 류상범 | 흡수식 냉온수기용 엘리미네이터 |
| CA2872644A1 (en) | 2012-05-31 | 2013-12-05 | Allergan Pharmaceuticals International Limited | Formulations and methods for vaginal delivery of antiprogestins |
| US9545411B2 (en) | 2012-11-02 | 2017-01-17 | Repros Therapeutics Inc. | Methods and compositions for treating progesterone-dependent conditions |
| CN116172995A (zh) * | 2023-01-17 | 2023-05-30 | 浙江大学医学院附属妇产科医院 | 一种沙丁胺醇在制备治疗子宫内膜异位症的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4241087A (en) * | 1979-04-02 | 1980-12-23 | William H. Rorer, Inc. | Dysmenorrhea treatment |
| NZ232801A (en) * | 1989-03-07 | 1992-01-29 | Adeza Biomedical Corp | Diagnostic test for endometriosis |
| JP2602456B2 (ja) * | 1990-04-12 | 1997-04-23 | 雪印乳業株式会社 | 子宮内膜症治療剤 |
| IT1251114B (it) * | 1991-07-26 | 1995-05-04 | Farcon Ag | Forme farmaceutiche antivirali per applicazione vaginale |
| DE69819748T2 (de) * | 1997-09-12 | 2004-09-30 | Columbia Laboratories (Bermuda) Ltd. | Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen |
-
2000
- 2000-04-10 UA UA2002043631A patent/UA74168C2/uk unknown
- 2000-10-03 MY MYPI20004608A patent/MY129518A/en unknown
- 2000-10-03 PE PE2000001044A patent/PE20010742A1/es not_active Application Discontinuation
- 2000-10-04 HU HU0203050A patent/HU225990B1/hu unknown
- 2000-10-04 JP JP2001527787A patent/JP2003510354A/ja active Pending
- 2000-10-04 NZ NZ518429A patent/NZ518429A/en not_active IP Right Cessation
- 2000-10-04 BR BR0014548-3A patent/BR0014548A/pt not_active Application Discontinuation
- 2000-10-04 AU AU75250/00A patent/AU780736B2/en not_active Ceased
- 2000-10-04 GE GE4769A patent/GEP20043313B/en unknown
- 2000-10-04 DK DK00964272T patent/DK1220667T3/da active
- 2000-10-04 CN CNB008138079A patent/CN1218694C/zh not_active Expired - Fee Related
- 2000-10-04 WO PCT/EP2000/009708 patent/WO2001024788A2/en not_active Ceased
- 2000-10-04 TR TR2002/00899T patent/TR200200899T2/xx unknown
- 2000-10-04 HK HK02105660.6A patent/HK1044120B/en not_active IP Right Cessation
- 2000-10-04 DE DE60012554T patent/DE60012554T2/de not_active Expired - Lifetime
- 2000-10-04 MX MXPA02003453A patent/MXPA02003453A/es active IP Right Grant
- 2000-10-04 PT PT00964272T patent/PT1220667E/pt unknown
- 2000-10-04 CO CO00075387A patent/CO5251423A1/es not_active Application Discontinuation
- 2000-10-04 ES ES00964272T patent/ES2223581T3/es not_active Expired - Lifetime
- 2000-10-04 CA CA2385974A patent/CA2385974C/en not_active Expired - Fee Related
- 2000-10-04 EP EP00964272A patent/EP1220667B1/en not_active Expired - Lifetime
- 2000-10-04 AR ARP000105228A patent/AR028487A1/es unknown
- 2000-10-04 KR KR1020027004330A patent/KR100738724B1/ko not_active Expired - Fee Related
- 2000-10-04 IL IL14878400A patent/IL148784A0/xx active IP Right Grant
- 2000-10-04 AT AT00964272T patent/ATE271860T1/de active
- 2000-10-27 TW TW089120706A patent/TWI280877B/zh not_active IP Right Cessation
-
2002
- 2002-03-20 IL IL148784A patent/IL148784A/en not_active IP Right Cessation
- 2002-04-04 MA MA26584A patent/MA25501A1/fr unknown
- 2002-04-04 NO NO20021591A patent/NO329663B1/no not_active IP Right Cessation
-
2009
- 2009-10-29 JP JP2009249023A patent/JP2010018639A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9914901A (pt) | Agonistas do receptor 5ht1 e metoclopramida para o tratamento de enxaqueca | |
| BRPI9913945B8 (pt) | Composição farmacêutica rapidamente atuante para a administração sublingual de um agente farmacêutico para o tratamento de distúrbios agudos | |
| UY25794A1 (es) | Procedimiento para la preparacion de compuestos derivados de adeninas, que son agonistas del receptor de la adenosina a2a | |
| BR9811099A (pt) | Inibidores de urocinase | |
| PT804252E (pt) | Agentes queladores metalicos que contem monoaminas diamidas e tiois | |
| BR0313602A (pt) | Método e formulação de complexo de aripiprazol | |
| WO2000008015A3 (en) | Fsh mimetics for the treatment of infertility | |
| FI954944A0 (fi) | Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon | |
| BRPI0416752A (pt) | composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica | |
| BR0111196A (pt) | Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus | |
| AU1741295A (en) | Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin | |
| MXPA01009552A (es) | Metodo para proteger, preservar e interrumpir el funcionamiento de un organo. | |
| BRPI0309769B8 (pt) | composição lubrificante substancialmente anidra | |
| BR9915818A (pt) | Processo e composições para a prevenção de tolerância a medicações | |
| NO20024221L (no) | Blandinger inneholdende alfa-2-adrenerge agonistkomponenter | |
| BR9908857A (pt) | Métodos e composições para tratamento, inibição e prevenção de mucosite | |
| BG101446A (bg) | Антинеопластични какаови екстракти, метод за получаване и използване | |
| BR0014767A (pt) | Fibras de sementes de plantas e uso | |
| AU3419995A (en) | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence | |
| BR9813684A (pt) | Processo para tratar o glaucoma glc1a, e, composição para controlar o glaucoma glc1a. | |
| BR0009524A (pt) | Uso de um composto, e, composição farmacêutica ou veterinaria | |
| BR0115952A (pt) | Composição de emulsão para administração terapêutica, método de administração, processo para o preparo de uma formulação contendo derivados de fosfato de agentes de transferência de elétrons | |
| BR9908510A (pt) | Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana | |
| BR0008297A (pt) | Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma | |
| BR0201524A (pt) | Tratamento de combinação para ansiedade e depressão |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24, 25 DA LPI |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |